Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Mahmod, Masliza ^a   Francis, Jane M ^a   Pal, Nikhil ^a   Lewis, Andrew ^a   Dass, Sairia ^a   De Silva, Ravi ^b   Petrou, Mario ^b   Sayeed, Rana ^b   Westaby, Stephen ^b   Robson, Matthew D ^a   Ashrafian, Houman ^a   Neubauer, Stefan ^a   Karamitsos, Theodoros D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Energetics; Hypertrophy; Microvascular dysfunction; Myocardial ischaemia; Oxygenation; Strain

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; OXYGEN;

AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; BOLD SIGNAL; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLAUSTROPHOBIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY TRANSFER; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; MYOCARDIAL OXYGENATION; NATIONAL HEALTH SERVICE; OXYGEN BLOOD LEVEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRESS; TISSUE OXYGENATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY CIRCULATION; ENERGY METABOLISM; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; OXYGEN CONSUMPTION; PHOSPHOCREATINE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84899932892     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-29     Document Type: Article

References (39)

1. Aortic stenosis and angina with normal coronary arteries: the role of coronary flow abnormalities. Irvine T, Kenny A, Heart 1997 78 213 4
2. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, Camici PG, Circulation 2002 105 470 6
3. Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. Steadman CD, Jerosch-Herold M, Grundy B, Rafelt S, Ng LL, Squire IB, Samani NJ, McCann GP, JACC Cardiovasc Imaging 2012 5 182 9
4. Oxygenation-sensitive cardiovascular magnetic resonance. Friedrich MG, Karamitsos TD, J Cardiovasc Magn Reson 2013 15 43
5. Diagnostic accuracy of adenosine stress cardiovascular magnetic resonance following acute ST-segment elevation myocardial infarction post primary angioplasty. Wong DT, Leung MC, Das R, Liew GY, Williams K, Dundon BK, Molaee P, Teo KS, Meredith IT, Worthley MI, Worthley SG, J Cardiovasc Magn Reson 2011 13 62
6. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S, Lancet 2012 379 453 60
7. Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation. Vohringer M, Flewitt JA, Green JD, Dharmakumar R, Wang J Jr, Tyberg JV, Friedrich MG, J Cardiovasc Magn Reson 2010 12 20
8. Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3-T cardiovascular magnetic resonance imaging study. Karamitsos TD, Arnold JR, Pegg TJ, Francis JM, Birks J, Jerosch-Herold M, Neubauer S, Selvanayagam JB, Circ Cardiovasc Imaging 2012 5 194 200
9. Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. Arnold JR, Karamitsos TD, Bhamra-Ariza P, Francis JM, Searle N, Robson MD, Howells RK, Choudhury RP, Rimoldi OE, Camici PG, Banning AP, Neubauer S, Jerosch-Herold M, Selvanayagam JB, J Am Coll Cardiol 2012 59 1954 64
10. BOLD New directions in myocardial ischemia imaging-myocardial oxygenation assessment by cardiac magnetic resonance. Weinsaft JW, Spincemaille P, J Am Coll Cardiol 2012 59 1965 7
11. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK, Lancet 1991 338 973 6
12. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. Neubauer S, Horn M, Pabst T, Harre K, Stromer H, Bertsch G, Sandstede J, Ertl G, Hahn D, Kochsiek K, J Invest Med 1997 45 453 62
13. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, Francis JM, J Cardiovasc Magn Reson 2007 9 777 83
14. Single breath-hold slice-following CSPAMM myocardial tagging. Stuber M, Spiegel MA, Fischer SE, Scheidegger MB, Danias PG, Pedersen EM, Boesiger P, MAGMA 1999 9 85 91
15. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T. Tyler DJ, Emmanuel Y, Cochlin LE, Hudsmith LE, Holloway CJ, Neubauer S, Clarke K, Robson MD, NMR Biomed 2009 22 405 13
16. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Karamitsos TD, Leccisotti L, Arnold JR, Recio-Mayoral A, Bhamra-Ariza P, Howells RK, Searle N, Robson MD, Rimoldi OE, Camici PG, Neubauer S, Selvanayagam JB, Circ Cardiovasc Imaging 2010 3 32 40
17. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE, Searle N, Channon KM, Banning AP, Neubauer S, Circulation 2005 112 3289 96
18. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 83
19. Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis. Mahmod M, Bull S, Suttie JJ, Pal N, Holloway C, Dass S, Myerson SG, Schneider JE, de Silva R, Petrou M, Sayeed R, Westaby S, Clelland C, Francis JM, Ashrafian H, Karamitsos TD, Neubauer S, Circ Cardiovasc Imaging 2013 6 808 16
20. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E, Circulation 2003 108 432 7
21. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC, JACC Cardiovasc Imaging 2011 4 150 6
22. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Rajappan K, Rimoldi OE, Camici PG, Bellenger NG, Pennell DJ, Sheridan DJ, Circulation 2003 107 3170 5
23. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Delgado V, Tops LF, van Bommel RJ, van der Kley F, Marsan NA, Klautz RJ, Versteegh MI, Holman ER, Schalij MJ, Bax JJ, Eur Heart J 2009 30 3037 47
24. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function. Beyerbacht HP, Lamb HJ, van der Laarse A, Vliegen HW, Leujes F, Hazekamp MG, de Roos A, van der Wall EE, Radiology 2001 219 637 43
25. Alterations in the coronary circulation in hypertrophied ventricles. Marcus ML, Harrison DG, Chilian WM, Koyanagi S, Inou T, Tomanek RJ, Martins JB, Eastham CL, Hiratzka LF, Circulation 1987 75 19 25
26. Myocardial oxygen consumption during exercise in the presence of left ventricular hypertrophy secondary to supravalvular aortic stenosis. Bache RJ, Dai XZ, J Am Coll Cardiol 1990 15 1157 64
27. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL, N Engl J Med 1982 307 1362 6
28. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Laine H, Katoh C, Luotolahti M, Yki-Jarvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J, Circulation 1999 100 2425 30
29. Wall stress and hypertension. James MA, Saadeh AM, Jones JV, J Cardiovasc Risk 2000 7 187 90
30. Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. Karamitsos TD, Dass S, Suttie J, Sever E, Birks J, Holloway CJ, Robson MD, Jerosch-Herold M, Watkins H, Neubauer S, J Am Coll Cardiol 2013 61 1169 76
31. Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging. Beache GM, Herzka DA, Boxerman JL, Post WS, Gupta SN, Faranesh AZ, Solaiyappan M, Bottomley PA, Weiss JL, Shapiro EP, Hill MN, Circulation 2001 104 1214 7
32. The creatine-creatine phosphate energy shuttle. Bessman SP, Carpenter CL, Annu Rev Biochem 1985 54 831 62
33. The failing heart-an engine out of fuel. Neubauer S, N Engl J Med 2007 356 1140 51
34. Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. Lygate CA, Aksentijevic D, Dawson D, ten Hove M, Phillips D, de Bono JP, Medway DJ, Sebag-Montefiore L, Hunyor I, Channon KM, Clarke K, Zervou S, Watkins H, Balaban RS, Neubauer S, Circ Res 2013 112 945 55
35. Profiles of coronary blood flow velocity in patients with aortic stenosis and the effect of valve replacement: a transthoracic echocardiographic study. Kenny A, Wisbey CR, Shapiro LM, Br Heart J 1994 71 57 62
36. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC, Eur Heart J Cardiovasc Imaging 2012 13 819 26
37. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G, Strotmann JM, Circulation 2009 120 577 84
38. The effect of nitroglycerine on left ventricular wall tension in fixed orifice aortic stenosis. Perloff JG, Ronan JA Jr, Deleon AC Jr, Circulation 1965 32 204 13
39. Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis. Unger SA, Robinson MA, Horowitz JD, Aust N Z J Med 1997 27 24 8